The mitochondrial UPR induced by ATF5 attenuates intervertebral disc degeneration via cooperating with mitophagy

Author:

Xu Wen-Ning1,Zheng Huo-Liang2,Yang Run-Ze3,Sun Yuan-Fang1,Peng Bi-Rong1,Song Jian2,Jiang Sheng-Dan2,Zhu Li-Xin1

Affiliation:

1. Orthopedic Medical Center, Southern Medical University

2. Shanghai Jiaotong University School of Medicine

3. West China Hospital of Sichuan University

Abstract

Abstract Intervertebral disc degeneration (IVDD) is an aging disease that results in a low quality of life and heavy socioeconomic burden. The mitochondrial unfolded protein response (UPRmt) is involved in various aging-related diseases. Our study aims to investigate the role and underlying mechanism of UPRmt in IVDD. Nucleus pulposus (NP) cells were treated by IL-1β and nicotinamide riboside (NR) served as UPRmt inducer to treat NP cells. TUNEL assay, Western blot and Flow cytometry were used to determine the apoptosis of NP cells. Detection of ATP, NAD + and NADH were used to determine the function of mitochondria. MRI, Safranin O-fast green staining and Immunohistochemical examination were used to determine the degree of IVDD in vivo. In the present study, we discovered that the level of UPRmt was significantly lower in the human tissue of patients with IVDD than in healthy controls. In vitro, UPRmt and mitophagy levels were promoted in NP cells after IL-1β treatment. Upregulation of UPRmt by NR and Atf5 overexpression inhibited the apoptosis of NP cells induced by IL-1β treatment and further improved mitophagy. Silencing of Pink1 reversed the protective effects of NR and inhibited mitophagy induced by the UPRmt. In vivo, NR might attenuate the degree of IDD by activating the UPRmt in rats. In summary, the UPRmt was involved in IVDD by regulating Pink1-induced mitophagy. Mitophagy induced by the UPRmt might be a potential therapeutic target for IVDD.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3